2019 GHS Index Country Profile for United States

United States Overall

5%

Only 5% of countries have a publicly available plan or policy that extends beyond influenza for sharing genetic data, clinical specimens, and/or isolated biological materials.
No countries have legislation or regulations in place that require companies to screen DNA synthesis orders to prevent the building blocks of dangerous pathogens from falling into the hands of malicious actors.

Score Simulator

Use the score simulator tool to see how a country’s overall and category scores can change when adjustments are made across the subindicators.

Country Comparison